Real-World Comparative Outcomes of Dual vs. Single Antiplatelet Therapy in Acute Ischemic Stroke: A Retrospective Cohort Analysis
The addition of a second antiplatelet agent did not significantly reduce the long-term risk of stroke recurrence or mortality in patients with AIS over a 12-month period. Further studies are needed to assess long-term benefits and risks of DAPT in different stroke subpopulations.
Authors
- Alqassem Y. Hakami (ORCID: https://orcid.org/0000-0003-2477-1339)
- Amani Y. Alhalwani (ORCID: https://orcid.org/0000-0003-2734-2767)
- Yasser Alatawi (ORCID: https://orcid.org/0000-0001-8167-6931)
- Salwa Y. Hafez (ORCID: https://orcid.org/0000-0002-5986-5186)
- Eman A. Alraddadi
- Faisal Almutawa (ORCID: https://orcid.org/0009-0009-0418-8323)
- Ghaida Altowairqi
- Mehaf Ferak
- Khadijah Bamusa
- Asail Alkhathami
- Sarah Algamedi
- Faisal F. Alamri
Institutions
- King Abdulaziz University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdullah International Medical Research Center (SA)
- University of Tabuk (SA)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1007/s40120-025-00880-1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Abdullah International Medical Research Center